Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Change in Receivables (2017 - 2018)

ENDRA Life Sciences (NDRA) has disclosed Change in Receivables for 2 consecutive years, with -$12275.0 as the latest value for Q4 2018.

  • Quarterly Change in Receivables fell 279.2% to -$12275.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$12275.0 through Sep 2019, down 200.0% year-over-year, with the annual reading at -$6850.0 for FY2018, 200.0% down from the prior year.
  • Change in Receivables for Q4 2018 was -$12275.0 at ENDRA Life Sciences, down from $505.0 in the prior quarter.
  • The five-year high for Change in Receivables was $6850.0 in Q4 2017, with the low at -$12275.0 in Q4 2018.